http://www.onemedplace.com/blog/wp-content/uploads/2009/08/scientist.jpg
The 160,000 square-foot facility could bring at least 300 jobs to Georgia.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/06/vaccine.jpg
Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space, recent advancements and study results are encouraging.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/01/vials.jpg
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/05/test_tubes.jpg
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
View ArticleBulls, Bears: The State of Cancer Immunotherapy in the Public Markets
This is Part II of our special report on the state of immunotherapy in the public markets. This report looks at promising anticancer immunotherapy technologies, and the major issues in bringing these...
View Article
More Pages to Explore .....